Varicella-zoster virus (VZV) infection of differentiated cells within the host and establishment of latency likely requires evasion of innate immunity and limits secretion of antiviral cytokines. Here we report that its immediate-early protein ORF61 antagonizes the beta interferon (IFN-) pathway. VZV infection down-mod-Varicella-zoster virus (VZV) is ubiquitous in most of the population worldwide and is an alphaherpesvirus restricted to humans. Primary VZV infection begins with inoculation of the respiratory mucosa, followed by cell-associated viremia and the rash of chickenpox. During primary infection, the virus establishes latency in sensory ganglia and can subsequently reactivate to cause shingles (herpes zoster) (3). The VZV genome contains one copy of linear double-strand DNA approximately 125 kb in length and encodes about 70 unique proteins. Similar to other alphaherpesviruses, the expression of VZV genes is assorted temporally into three categories-immediate-early (IE), early (E), and late (L)-and the IE proteins usually play critical roles during VZV life cycles (29).ORF61 encodes a 62-to 66-kDa phosphoprotein (45), which is highly homologous to herpes simplex virus 1 (HSV-1) ICP0 in the RING finger domain and can partially complement the function of ICP0 in ICP0-null HSV-1 (28). Both proteins exhibit regulatory functions, but the difference between them is that ORF61 has either a transactivated or repressive function (16, 31), while ICP0 mostly shows transcriptional activation (12,14). Although ICP0 can inhibit the innate immunity pathway at many levels, such as IRF3 and PML (13,26), little is known about the function of ORF61 in interrupting the innate immunity.The innate immune system is an ancient and nonspecific system that provides the first line of defense against infection. One of the most effective innate antiviral responses is the production of alpha/beta interferon (IFN-␣/) and the subsequent induction of interferon-stimulated genes (ISGs) (38). Previous studies have demonstrated that VZV infection stimulates innate immune responses mainly by the production of IFN-␣ and IFN-␥ (1, 2, 27), while IFN- is not detected in serum of VZV-infected patients. This might be explained by the evidence provided by one group that the production of IFN- may be blocked by ORF62 during VZV infection (40).Increasing evidence has shown that ICP0 possesses various antagonistic functions against the host innate immune system